PYXS vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 16, 2026

PYXS

46.5
AI Score
VS
PYXS Wins

CBIO

36.3
AI Score

Investment Advisor Scores

PYXS

47score
Recommendation
HOLD

CBIO

36score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PYXS CBIO Winner
Revenue 2.82M 1.04M PYXS
Net Income -39.51M -48.12M PYXS
Net Margin -1401.1% -4631.4% PYXS
Operating Income -42.66M -51.09M PYXS
ROE -45.1% -29.5% CBIO
ROA -32.1% -26.3% CBIO
Total Assets 123.22M 182.76M CBIO
Cash 10.73M 171.59M CBIO
Current Ratio 5.65 9.66 CBIO

Relative Price Performance (Last 90 Days)

PYXS 1M: -36.3% · 3M: -16.7% CBIO 1M: -20.5% · 3M: -16.6%

Current Technical Phase

PYXS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 30

RSI (14): 29.9 · Price: $2.19

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 35

RSI (14): 35.1 · Price: $14.26

Fundamentals Snapshot

Metric PYXS CBIO
Market Cap — —
Forward P/E -1.9 -5.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.8% 1.0%
Operating Margin -8.1% -14.3%
EPS -1.40 -0.14
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PYXS is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.